60

Weihai Baihe Biology Technological Co. Ltd.

603102 · SHG · Consumer Defensive / Packaged Foods

32.26CNY-0.69 (-2.09%)

Price History

Full chart

Market Stats

Previous Close32.95
Open32.98
Day Range32.14 – 33.06
52-Week Range29.91 – 47.62
Volume967.30K
Market Cap2.39B
P/E (TTM)19.42
Forward P/E0.00
EPS1.92
Dividend Yield2.01%
Beta0.48
50-Day Avg37.63
200-Day Avg39.54

About

Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food products in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutritional soft candies; special diet products comprising supplementary food and nutritional supplements, nutritional supplements for pregnant women and lactating mothers, and sports nutrition supplements; and official approval services for health food declarations, as well as produces and sells pet food. It provides its products in the form of soft and hard capsules, tablets, powders, oral liquids, drops, and bottled and bagged beverages. The company sells its products under the Biohek, Hongyangshen, Yunyangyan, Forzal, Zulixing, and Nengbeijian brands. It also exports its products to approximately 70 countries, including Europe and the United States. Weihai Baihe Biology Technological Co., Ltd. was founded in 1996 and is headquartered in Rongcheng, China.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Xinli Liu
  • Employees1.10K
  • HeadquartersNo. 552, Chengda Road, Rongcheng, China, 264321, China
  • Websitehttps://www.baiheshengwu.com

Leadership

  • Mr. Xinli LiuGM & Chairman of the Board · b. 1962
  • Xin Zhi LiuAccounting Supervisor

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue499.63M578.29M661.87M725.33M871.25M801.40M910.93M
Growth (%)-+15.74%+14.45%+9.59%+20.12%-8.02%+13.67%
Cost of Revenue295.55M325.39M386.83M461.30M545.34M508.92M588.92M
Gross Profit204.08M252.89M275.04M264.03M325.91M292.48M322.00M
Gross Margin40.85%43.73%41.55%36.40%37.41%36.50%35.35%
Operating Expense107.40M101.03M106.56M114.65M142.51M144.15M172.09M
Operating Income96.68M151.87M168.48M149.37M183.40M148.33M149.91M
Operating Margin19.35%26.26%25.45%20.59%21.05%18.51%16.46%
EBITDA100.56M155.45M193.24M191.48M231.08M202.13M199.22M
EBITDA Margin20.13%26.88%29.20%26.40%26.52%25.22%21.87%
Net Income74.33M127.12M148.04M137.84M169.07M139.31M128.43M
Net Income Margin14.88%21.98%22.37%19.00%19.40%17.38%14.10%
R&D17.77M20.74M24.06M22.51M30.95M35.78M35.89M
R&D as % of Total Revenue3.56%3.59%3.64%3.10%3.55%4.47%3.94%
Interest Expense--150.41K131.06K101.86K79.20K309.60K
Interest Expense % of Total Revenue--0.02%0.02%0.01%0.01%0.03%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets620.18M731.02M915.92M1.66B1.74B1.82B1.96B
Total Liabilities157.26M150.94M202.20M239.93M221.70M209.81M269.48M
Total Equity462.92M580.08M713.72M1.42B1.51B1.61B1.66B
Cash291.95M384.70M414.17M1.10B1.14B1.13B1.14B

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow121.36M150.00M169.15M152.91M193.85M127.65M186.02M
Capital Expenditure20.16M33.97M124.55M51.54M96.52M94.92M55.66M
Free Cash Flow101.20M116.03M44.60M101.36M97.33M32.73M130.36M
Dividends Paid23.52M23.52M14.40M32.00M38.40M47.23M46.71M
FCF to OCF83.39%77.35%26.37%66.29%50.21%25.64%70.08%
Dividend Paid to FCF23.24%20.27%32.28%31.57%39.45%144.31%35.83%

Earnings

Report DateMar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate------
EPS Actual0.490.630.550.490.700.82
Surprise------
Timing------

Key Statistics & Ratios

Market Cap2.39B
Enterprise Value1.30B
Trailing P/E19.42
Forward P/E0.00
Price / Sales2.40
Price / Book1.41
EPS1.92
Book Value27.52
Revenue (TTM)994.19M
Gross Profit (TTM)343.59M
EBITDA193.26M
Profit Margin11.93%
Operating Margin13.39%
Return on Equity7.57%
Return on Assets4.72%
Shares Outstanding64.00M
Shares Float27.08M
Beta0.48
Dividend Yield2.01%
Dividend Rate0.75
Payout Ratio38.86%

Dividends

20261×
0.75Aug 27, 2026
20251×
0.75Aug 5, 2025
20241×
0.75Jun 3, 2024
20231×
0.60May 16, 2023
20221×
0.50May 24, 2022